Insmed Other Income (Expense) increased by 59.6% to -$736.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 657.6%, from $132.00K to -$736.00K. Over 2 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a -25.6% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$159.00K | -$476.00K | -$2.65M | -$1.25M | -$4.31M | -$1.51M | -$111.00K | -$488.00K | $285.00K | $2.17M | -$1.10M | -$269.00K | $1.84M | $132.00K | $453.00K | -$603.00K | -$1.82M | -$736.00K |
| QoQ Change | — | -199.4% | -457.1% | +52.9% | -244.8% | +64.8% | +92.7% | -339.6% | +158.4% | +661.4% | -150.7% | +75.5% | +785.1% | -92.8% | +243.2% | -233.1% | -202.3% | +59.6% |
| YoY Change | — | — | — | — | <-999% | -218.1% | +91.1% | +88.7% | +118.8% | — | -891.0% | +44.9% | +546.7% | +112.0% | +268.4% | -132.7% | — | -657.6% |